Drug release kinetics and physicochemical characteristics of floating drug delivery systems

被引:33
作者
Adibkia, Khosro [1 ]
Hamedeyazdan, Sanaz [3 ]
Javadzadeh, Yousef [1 ,2 ]
机构
[1] Tabriz Univ Med Sci, Biotechnol Res Ctr, Tabriz 51664, Iran
[2] Drug Appl Res Ctr, Tabriz 51664, Iran
[3] Tabriz Univ Med Sci, Fac Pharm, Tabriz 51664, Iran
关键词
buoyancy; drug release kinetics; effervescent and non-effervescent systems; floating drug delivery systems; IN-VITRO EVALUATION; HYDRODYNAMICALLY BALANCED SYSTEMS; GASTRORETENTIVE DOSAGE FORMS; SILICATE BASED MICROSPHERES; EMULSION GEL BEADS; SUSTAINED-RELEASE; HOLLOW MICROSPHERES; CALCIUM PECTINATE; VIVO EVALUATION; MATRIX TABLETS;
D O I
10.1517/17425247.2011.574124
中图分类号
R9 [药学];
学科分类号
100702 [药剂学];
摘要
Introduction: Absorption of drugs through the gastrointestinal tract poses a variety of limitations, making the in vivo performance of drug delivery systems uncertain. Following on from recent advances, in a time of increased consideration of floating drug delivery systems, it is as important as ever to continue the progress by studying different aspects of these systems. Moreover, it seems imperative to gain a deeper insight into drug release mechanisms, in order to design a more systematic and intellectual floating system. Areas covered: This paper summarizes current approaches in the research and development of ideal floating drug delivery systems, from recent literature. Also, in order to have predictability and reproducibility in designing an efficient floating dosage form, some kinetic studies are mentioned, and the drug release mechanism from floating drug delivery systems is discussed. Expert opinion: Developing an efficient floating dosage form is reliant on a better understanding of the relation between formulation variables and performance of the floating systems. Generally, the combination of two buoyancy mechanisms and gas-generating systems with swellable polymers would be beneficial for obtaining an appropriate floating lag time and duration of buoyancy, which in turn guarantees optimum efficiency of the pharmaceutical dosage form.
引用
收藏
页码:891 / 903
页数:13
相关论文
共 114 条
[1]
Porous Carriers for Controlled/Modulated Drug Delivery [J].
Ahuja, G. ;
Pathak, K. .
INDIAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2009, 71 (06) :599-607
[2]
Formulation and development of hydrodynamically balanced system for metformin:: In vitro and in vivo evaluation [J].
Ali, Javed ;
Arora, Shweta ;
Ahuja, Alka ;
Babbar, Anil K. ;
Sharma, Rakesh K. ;
Khar, Roop K. ;
Baboota, Sanjula .
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS, 2007, 67 (01) :196-201
[3]
Mathematical modeling and simulation of drug release from microspheres: Implications to drug delivery systems [J].
Arifin, Davis Yohanes ;
Lee, Lai Yeng ;
Wang, Chi-Hwa .
ADVANCED DRUG DELIVERY REVIEWS, 2006, 58 (12-13) :1274-1325
[4]
Formulation and Evaluation of Swellable and Floating Gastroretentive Ciprofloxacin Hydrochloride Tablets [J].
Arza, Ramji Anil Kumar ;
Gonugunta, Chandra Sekhara Rao ;
Veerareddy, Prabhakar Reddy .
AAPS PHARMSCITECH, 2009, 10 (01) :220-226
[5]
ASNAASHARI S, 2010, PHARM DEV TECHN 0430
[6]
Development and Evaluation of Sustained Release Gastroretentive Minimatrices for Effective Treatment of H. pylori Infection [J].
Badhan, Atul C. ;
Mashru, Rajashree C. ;
Shah, Punit P. ;
Thakkar, Arti R. ;
Dobaria, Nitin B. .
AAPS PHARMSCITECH, 2009, 10 (02) :459-467
[7]
Development of hollow/porous calcium pectinate beads for floating-pulsatile drug delivery [J].
Badve, Shraddha S. ;
Sher, Praveen ;
Korde, Aruna ;
Pawar, Atmaram P. .
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS, 2007, 65 (01) :85-93
[8]
Formulation and evaluation of multiple tablets as a biphasic gastroretentive floating drug delivery system for fenoverine [J].
Bandari, Suresh ;
Eaga, Chandra Mohan ;
Thadishetty, Ashok ;
Yamsani, Madhusudan Rao .
ACTA PHARMACEUTICA, 2010, 60 (01) :89-97
[9]
Prolonged Intragastric Drug Delivery Mediated by EudragitA® E-Carrageenan Polyelectrolyte Matrix Tablets [J].
Bani-Jaber, Ahmad ;
Al-Aani, Leena ;
Alkhatib, Hatim ;
Al-Khalidi, Bashar .
AAPS PHARMSCITECH, 2011, 12 (01) :354-361
[10]
Gastroretentive dosage forms:: Overview and special case of Helicobacter pylori [J].
Bardonnet, PL ;
Faivre, V ;
Pugh, WJ ;
Piffaretti, JC ;
Falson, F .
JOURNAL OF CONTROLLED RELEASE, 2006, 111 (1-2) :1-18